AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
+1%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.33B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$211M |
| 2 |
Cigna
CI
|
+$198M |
| 3 |
Comcast
CMCSA
|
+$163M |
| 4 |
Zoom
ZM
|
+$148M |
| 5 |
Johnson & Johnson
JNJ
|
+$136M |
Top Sells
| 1 |
Humana
HUM
|
+$263M |
| 2 |
TSMC
TSM
|
+$245M |
| 3 |
NVIDIA
NVDA
|
+$168M |
| 4 |
Adobe
ADBE
|
+$151M |
| 5 |
Pultegroup
PHM
|
+$120M |
Sector Composition
| 1 | Technology | 24.6% |
| 2 | Financials | 13.87% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Industrials | 12.41% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
2051
Diversified Healthcare Trust
DHC
$1.07B
| $507K | ﹤0.01% |
166,215
+93,421
| +128% | +$285K |
|
2052
Lemonade
LMND
$3.88B
| $506K | ﹤0.01% |
30,687
-19,564
| -39% | -$323K |
|
2053
Broadstone Net Lease
BNL
$3.55B
| $505K | ﹤0.01% |
31,825
-15,993
| -33% | -$254K |
|
2054
Unifirst Corp
UNF
$3.18B
| $504K | ﹤0.01% |
2,937
+1,365
| +87% | +$234K |
|
2055
Merus
MRUS
$5.26B
| $501K | ﹤0.01% |
8,470
-332
| -4% | -$19.6K |
|
2056
Essential Properties Realty Trust
EPRT
$5.91B
| $500K | ﹤0.01% |
18,047
+6,519
| +57% | +$181K |
|
2057
Vitesse Energy
VTS
$968M
| $499K | ﹤0.01% |
21,054
-22,247
| -51% | -$527K |
|
2058
Revolution Medicines
RVMD
$8.7B
| $498K | ﹤0.01% |
+12,832
| New | +$498K |
|
2059
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$6.15B
| $495K | ﹤0.01% |
18,529
+9,427
| +104% | +$252K |
|
2060
UFP Technologies
UFPT
$1.54B
| $494K | ﹤0.01% |
1,872
-371
| -17% | -$97.9K |
|
2061
Cadre Holdings
CDRE
$1.32B
| $492K | ﹤0.01% |
14,663
-1,183
| -7% | -$39.7K |
|
2062
Avidity Biosciences
RNA
$5.76B
| $492K | ﹤0.01% |
+12,042
| New | +$492K |
|
2063
Vericel Corp
VCEL
$1.62B
| $491K | ﹤0.01% |
10,701
-5,367
| -33% | -$246K |
|
2064
Glaukos
GKOS
$4.75B
| $490K | ﹤0.01% |
4,141
+211
| +5% | +$25K |
|
2065
Expro
XPRO
$1.43B
| $489K | ﹤0.01% |
+21,347
| New | +$489K |
|
|
FL
2066
DELISTED
Foot Locker
FL
| $489K | ﹤0.01% |
19,928
-43,017
| -68% | -$1.06M |
|
2067
Invesco S&P MidCap Low Volatility ETF
XMLV
$817M
| $489K | ﹤0.01% |
8,853
| – | – |
|
2068
VanEck Semiconductor ETF
SMH
$28.8B
| $488K | ﹤0.01% |
+1,872
| New | +$488K |
|
2069
Sabesp
SBS
$16B
| $486K | ﹤0.01% |
36,161
+249
| +0.7% | +$3.35K |
|
2070
Summit Therapeutics
SMMT
$14.1B
| $484K | ﹤0.01% |
+62,114
| New | +$484K |
|
2071
Douglas Emmett
DEI
$2.79B
| $479K | ﹤0.01% |
36,432
+1,377
| +4% | +$18.1K |
|
2072
Utah Medical Products
UTMD
$200M
| $478K | ﹤0.01% |
+7,151
| New | +$478K |
|
2073
Glacier Bancorp
GBCI
$5.8B
| $476K | ﹤0.01% |
13,007
+1,627
| +14% | +$59.6K |
|
2074
Alta Equipment Group
ALTG
$239M
| $474K | ﹤0.01% |
58,919
+41,558
| +239% | +$334K |
|
|
NVRO
2075
DELISTED
NEVRO CORP.
NVRO
| $470K | ﹤0.01% |
+55,840
| New | +$470K |
|